Strength in diversity : Widening B cell recruitment for broader vaccine protection
Copyright © 2023 Elsevier Inc. All rights reserved..
Generating potent neutralizing antibodies is a unifying goal of next-generation vaccines. In this issue of Immunity, Ols et al. show that multivalent nanoparticle vaccines displaying RSV F protein can enable recruitment of more diverse B cell specificities into the vaccine response, resulting in increased potency and breadth of antibody immunity to both RSV and the related human metapneumovirus.
| Errataetall: |
CommentOn: Immunity. 2023 Oct 10;56(10):2425-2441.e14. - PMID 37689061 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:56 |
|---|---|
| Enthalten in: |
Immunity - 56(2023), 10 vom: 10. Okt., Seite 2182-2184 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Wheatley, Adam K [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antibodies, Neutralizing |
|---|
| Anmerkungen: |
Date Completed 13.10.2023 Date Revised 18.10.2023 published: Print CommentOn: Immunity. 2023 Oct 10;56(10):2425-2441.e14. - PMID 37689061 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.immuni.2023.09.009 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM363136347 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM363136347 | ||
| 003 | DE-627 | ||
| 005 | 20231226092716.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.immuni.2023.09.009 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1210.xml |
| 035 | |a (DE-627)NLM363136347 | ||
| 035 | |a (NLM)37820580 | ||
| 035 | |a (PII)S1074-7613(23)00414-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Wheatley, Adam K |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Strength in diversity |b Widening B cell recruitment for broader vaccine protection |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 13.10.2023 | ||
| 500 | |a Date Revised 18.10.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentOn: Immunity. 2023 Oct 10;56(10):2425-2441.e14. - PMID 37689061 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 Elsevier Inc. All rights reserved. | ||
| 520 | |a Generating potent neutralizing antibodies is a unifying goal of next-generation vaccines. In this issue of Immunity, Ols et al. show that multivalent nanoparticle vaccines displaying RSV F protein can enable recruitment of more diverse B cell specificities into the vaccine response, resulting in increased potency and breadth of antibody immunity to both RSV and the related human metapneumovirus | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Antibodies, Viral |2 NLM | |
| 650 | 7 | |a Antibodies, Neutralizing |2 NLM | |
| 650 | 7 | |a Vaccines |2 NLM | |
| 700 | 1 | |a Kent, Stephen J |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Immunity |d 1994 |g 56(2023), 10 vom: 10. Okt., Seite 2182-2184 |w (DE-627)NLM075097818 |x 1097-4180 |7 nnns |
| 773 | 1 | 8 | |g volume:56 |g year:2023 |g number:10 |g day:10 |g month:10 |g pages:2182-2184 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.immuni.2023.09.009 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 56 |j 2023 |e 10 |b 10 |c 10 |h 2182-2184 | ||